miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. - Wikidata - awgldk - TriplyDB

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

http://www.wikidata.org/entity/Q35404898

about

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy microRNA in the development of diabetic complications.Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expression High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.Regulation of NF-κB signaling by oxidized glycerophospholipid and IL-1β induced miRs-21-3p and -27a-5p in human aortic endothelial cells Differentially expressed wound healing-related microRNAs in the human diabetic cornea.MicroRNA profiling in intraocular medulloepitheliomas MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure Profiling of microRNAs involved in retinal degeneration caused by selective Müller cell ablation Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.MiRNA inhibition in tissue engineering and regenerative medicine.Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD)Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.MicroRNAs and diabetic complications MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.The physiological impact of microRNA gene regulation in the retina.Association study of polymorphisms in miRNAs with T2DM in Chinese population.miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes Let-7 contributes to diabetic retinopathy but represses pathological ocular angiogenesis.MicroRNAs in vitreus humor from patients with ocular diseases RNA Regulation of Lipotoxicity and Metabolic Stress.MicroRNAs: potential mediators and biomarkers of diabetic complications.Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy.Modulation of hippocampal gene expression of microRNA-146a/microRNA-155-nuclear factor-kappa B inflammatory signaling by troxerutin in healthy and diabetic rats.The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy.MicroRNAs in the Neural Retina.miRNAs regulate expression and function of extracellular matrix molecules.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Oxidative-stress-induced epigenetic changes in chronic diabetic complications.Epigenetics and ocular diseases: from basic biology to clinical study.Illustrating the interplay between the extracellular matrix and microRNAs.

P2860

Q26744760-10115BEE-FC3B-44A8-BFED-EB7048F736F3 Q26830676-7D041A3E-F408-46CA-9946-13955FA24B80 Q27320376-C0E40516-5336-415B-82C8-AD2554052CE3 Q28079163-C2F39460-AF03-4453-B87C-3DCEE43965D0 Q28354033-F0E29A29-D0EF-42B1-8763-A613757249F3 Q30009025-9AA4A0C7-7218-43DD-92F2-F5D9595B313F Q30353835-1C9E544A-C2E2-4A73-9342-BF64807E41A1 Q33863708-9B5C5814-6362-47C4-8F8A-517B1805A4E0 Q34138337-3E538AF0-41C5-41EC-B63D-16D3F9130F85 Q34266384-C3DEA6A0-702A-4CFF-B8CA-4BC30481477D Q34559494-E0837E74-BA25-4A9E-AE70-428684CD8EEC Q34757449-D52B86B7-074E-4944-B646-84424FB79C6F Q35078390-90B74F10-B1F6-4871-9929-2523C25787EE Q35217304-DB9BCD77-3E83-4736-9DF6-2A2FE7B0EAF2 Q35565357-E08F74C2-8A6D-47D4-89C6-D72FC3588854 Q35571995-1C4F1B53-77EC-4BA5-83D8-E75DCEF1DF24 Q35645997-CB9CB85F-C3D1-4B4A-BA57-8734F3A4B4CD Q35799937-3ABACB20-C0F1-4D3A-889B-F9625589FE70 Q35887465-63625175-2416-49DD-B614-47510E491615 Q36088154-5D504C80-7534-4E47-8930-706006E16A65 Q36094855-5FF8A88F-A2FF-458E-B295-60003C29F5E1 Q36166755-57A8D60A-B710-4B2B-A0CF-59FC765E1852 Q36205231-A09299E8-423C-4091-BB33-CEF84DE03F5C Q36238203-65A0B539-DCA7-4D02-9C4A-C161091D5C74 Q36275002-7157D1A9-2B21-4155-8352-74C0CF5F74CD Q36310864-1DAA6AE3-6665-4580-95DA-EAE871AA3879 Q36393604-2EC23697-FF99-47EA-A7D8-D6E88AAABB38 Q36634670-16930324-6A74-44FF-9744-BBC89BF665D6 Q37025632-ACADA9EE-7582-4D06-B1E8-8E4CB615EB01 Q37146727-3AC1BE5E-8846-4C60-A18A-D27672B0C34A Q37231719-C76969B5-CE67-43D8-AE5C-B11CABDAD086 Q37309486-EC31C261-27A7-4082-8B83-17F5973C0B84 Q37501976-6AA185DB-7CEA-4132-9E74-21F498EC66EF Q37512125-9B28340E-6952-4189-840E-CCA995620D54 Q37679588-3B759EFE-347F-452A-AF85-DF27B6978CED Q38060445-851328BE-1DFB-4E87-8AF2-4D0C12AE1015 Q38083574-307AEE40-119C-4DDC-A608-6A01C6004574 Q38093867-18FD4FB9-4DD3-4B82-B8D2-A1C94DC94E3E Q38169583-E8A87DE5-C4F2-48ED-BCC8-C27DBBEDACA1 Q38206794-7A02149D-A9F2-40A8-A702-F791FBCFDB74

P2860

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

http://www.wikidata.org/entity/Q35404898

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@ast

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@en

type

label

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@ast

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@en

prefLabel

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@ast

miR-146a-Mediated extracellula ...... hronic diabetes complications.

@en

P1433

Q35404898-D80E415E-B26E-474B-8422-DF84652A327C

P1476

Q35404898-837AE6C8-5B48-45BC-92AD-955C67DAD6AA

P2093

Q35404898-0337F2AE-90F0-461A-B92F-EB253BE1C1C3

Q35404898-08194150-5935-4681-8A33-9CADE5604454

Q35404898-20CB0E83-E8C8-4264-892A-602D42A29DC6

Q35404898-858B5E91-D346-40DE-862F-88207660A9A1

Q35404898-9909BF72-8EA8-4D23-AF3D-D4A120FA1207

Q35404898-F1B02ECD-BF7E-4C21-BE63-4136A29D7AE2

Q35404898-F9F85D02-AEFA-4396-8A03-3759E3D3AC1E

P2860

Q35404898-0A383DDC-D099-4CB0-86DE-E99467B9226D

Q35404898-11AF8DF0-AA89-40E0-A2D9-05CA7FA824DA

Q35404898-1F7E972C-5EC6-4A2E-8692-DA5598E2319D

Q35404898-265B68F5-7337-48A8-9247-26D6EC5465D6

Q35404898-27196D97-95F8-4634-915D-27CB9397EEA2

Q35404898-399B5923-093F-437A-9CE7-DD4A77B587B8

Q35404898-4A775811-D50B-4CB9-8959-BBD55EF5628F

Q35404898-51877D1E-5097-48E7-869E-B93F5E718012

Q35404898-5E891696-BBAF-4E57-80B0-8C03BC2E48A1

Q35404898-680D26FA-D5C4-4BD0-AE27-5EBC25B50EB9

P304

Q35404898-5F79C32C-E559-4D12-902F-7E1DB92A7D9F

P31

Q35404898-A38B0657-88F8-4061-8124-AF1E4FEF73F8

P356

Q35404898-D659C281-58E0-4C44-B178-C55B8A5AAC6F

P407

Q35404898-D2887271-0507-4ADF-A199-69FB1CB2AF5C

P433

Q35404898-7C17A219-11EA-4CA5-8E07-7B79BD56E277

P478

Q35404898-F3856D90-6F96-4631-B049-5AC840E97EB8

P50

Q35404898-8E61E534-8FE2-4214-9677-58138FD2B356

P577

Q35404898-EF37C220-CFD0-46B5-A43A-9D078A62F034

P5875

Q35404898-81EEAF0A-0BB4-4B88-AB80-87CF6065E9DF

P698

Q35404898-8F01011E-DF80-4391-A15A-0B6F8E3207EC

P921

Q35404898-22755967-D911-4F14-A1F7-AB1FB207CF25

P932

Q35404898-24DAB2E8-21C7-4152-A980-E1956F0A59BD

P356

P1433

P1476

miR-146a-Mediated extracellula ...... chronic diabetes complications

@en

P2093

Biao Feng

http://www.w3.org/2001/XMLSchema#string

Kara McArthur

http://www.w3.org/2001/XMLSchema#string

Qingming Ding

http://www.w3.org/2001/XMLSchema#string

Ross D Feldman

http://www.w3.org/2001/XMLSchema#string

Shali Chen

http://www.w3.org/2001/XMLSchema#string

Subhrojit Sen

http://www.w3.org/2001/XMLSchema#string

Yuexiu Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Increased enzyme activity and beta-adrenergic mediated vasodilation in subjects expressing a single-nucleotide variant of human adenylyl cyclase 6

The role of epigenetics in the pathology of diabetic complications

MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20

MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

MicroRNAs: small RNAs with a big role in gene regulation

Biochemistry and molecular cell biology of diabetic complications

Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy

MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts

Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300

MicroRNA-133 controls cardiac hypertrophy

P304

2975-2984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB11-0478

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Subrata Chakrabarti

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51613842

http://www.w3.org/2001/XMLSchema#string

P698

21885871

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

3198068

http://www.w3.org/2001/XMLSchema#string